You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Uzbekistan

Jun 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Uzbekistan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Uzbekistan, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Uzbekistan for free:

The Consumer Health in Uzbekistan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Uzbekistan?
  • What are the major brands in Uzbekistan?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health performs well after challenging year

Consumer health players in Uzbekistan struggled towards the end of the review period due to the impact of the global financial crisis. However, government reforms and initiatives have helped the national economy to overcome these challenges. As a result, consumer health recorded strong growth in 2010. This growth can be attributed to the rise of hard currency increase as well as rising consumer purchasing power.

Marketing campaigns fuel self-medication trend

After a tough year in 2009, manufacturers increased investment in marketing in 2010 in a bid to boost consumer awareness of the availability of self-medication products and of when and how to consume them - a development that helped to boost demand for such products.

Imports compete via promotion and quality whilst domestic and CIS players compete on price

Marketing strategies varied for different players in 2010. Promotional campaigns such as special cooperation programmes with medical personnel and direct adverts are mostly used by multinational companies to support their brands. In addition, sales of imported brands are also fuelled by the fact that they are perceived as being of good quality by consumers whilst domestic and CIS manufacturers rely on the competitive price of their brands and high consumer brand awareness.

Distribution limited to specific retailers that benefit from cooperation with manufacturers

All OTC brands are considered pharmaceutical products and are consequently only available via chemists and pharmacies. However, prices vary between smaller conveniently located and larger-scale centrally located chemists and pharmacies.

Despite being limited to chemists and pharmacies, the distribution of consumer health products improved in 2010, mainly thanks to useful cooperation agreements with representatives of manufacturers. These agreements help to improve product supply.

Consumer health players optimistic regarding forecast period

Consumer health sales will continue to increase over the forecast period due to a number of positive developments including continued population growth and rising living standards. In addition, manufacturers and distributors will also strengthen their marketing activities – a development that will help to boost consumer product awareness and further increase demand.

Table of Contents

Table of Contents

Consumer Health in Uzbekistan - Industry Overview

EXECUTIVE SUMMARY

Consumer health performs well after challenging year

Marketing campaigns fuel self-medication trend

Imports compete via promotion and quality whilst domestic and CIS players compete on price

Distribution limited to specific retailers that benefit from cooperation with manufacturers

Consumer health players optimistic regarding forecast period

KEY TRENDS AND DEVELOPMENTS

Government initiatives boosting number of chemists and pharmacies

Government incentives boost number of private medical centres

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins & Dietary Supplements Registration and Classification

Self-medication and preventative medicine

Generics

Switches

DEFINITIONS

Sources

  • Summary 1 Research Sources

Consumer Health in Uzbekistan - Company Profiles

Asklepiy Pharmaceutical Co in Consumer Health (Uzbekistan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

JV Jurabek Laboratories ltd in Consumer Health (Uzbekistan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Pharmed Pharmaceutical Co in Consumer Health (Uzbekistan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Although adult mouth care remains undeveloped in Uzbekistan, this does not mean that consumers in Uzbekistan are free from oral ailments. Instead, the main problem limiting sales in the area is poor supply and low consumer awareness.

SWITCHES

COMPETITIVE LANDSCAPE

  • Metrogil from Unique Pharmaceutical Laboratories accounted for nearly 20% of retail value sales in 2010 and was followed by Solcoseryl from Solco Basel (13%). Septolete from Krka and Trihopol of Polpharma accounted for 10% and 9% of total value sales each in 2010 and were followed by Anasep from Quramax (6%) and Flagil of Rhone-Poulenc Rorer (5%).

PROSPECTS

  • Adult mouth care has significant growth potential and domestic production is expected to improve during the review period – a development that will help to boost sales. However, the fact that local brands are relatively cheap means that their increasing popularity will have a negative impact on value growth over the coming years. As a result, the area has a projected forecast period constant retail value CAGR of <1%.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Analgesics continued to record positive growth during 2010 thanks to the availability of an increasing number of different types of products. The popularity of acetaminophen products continues to increase due to rising consumer awareness and producer marketing campaigns. In addition, the lack of any negative publicity regarding the potential harmful effects of analgesics is also helping to boost sales in this area.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bristol-Myers Squibb led analgesics sales in 2010, accounting for 32% of retail value sales. The company’s success can be attributed to the popularity of its Efferalgan and Fervex brands which recorded respective retail value shares of 15% and 14%. GlaxoSmithKline ranked second in 2010, accounting for 21% of retail value sales. The company’s Panadol brand, which accounted for 9% of retail value sales in 2010, continued to enjoy a high level of popularity within child-specific analgesics while Coldrex (6%) and Solpadeine (4%) also performed well thanks to the growing popularity of acetaminophen products.

PROSPECTS

  • Like any other consumer health area, analgesics sales will be fuelled by population growth and continuously improving living standards over the coming years. In addition, marketing support will also help to fuel demand for analgesics products. As a result of such favourable conditions, analgesics has a projected forecast period constant retail value CAGR of 2%.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • During the early part of the review period, calming and sleeping products were only consumed for sleeping purposes. However, active promotional campaigns have helped to increase consumer knowledge of the fact that such products can also be taken to combat stress and the effects of a hectic life-style. Overall, active promotional campaigns have helped to increase consumer awareness, with calming and sleeping current retail value sales increasing by 12% in 2010 to reach UZS6.2 billion.

COMPETITIVE LANDSCAPE

  • Ivax Corp, which produces the Novo-Passit brand, led value sales in 2010, recording a retail value share of 27%. Uzkhimpharm, which produces Dimedrol, ranked second with a retail value share of 15% and was followed by Bristol-Myers Squibb (Donornil – 12%) and Biotiki MNPK (Glicin – 12%). Other major calming and sleeping brands include Korvalol from Altayvitamini (10%), Biopassit from Unique Pharmaceutical Laboratories (6%), and Persen Forte from Lek Pharmaceuticals (6%).

PROSPECTS

  • Calming and sleeping sales are expected to continue to increase over the coming years due to the fact that people are consuming products in this area on a more regular basis. In addition, the number of people who consume products in the area in order to balance their emotions is also expected to rise.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies is the most developed consumer health area in Uzbekistan, accounting for 26% of current retail value sales in 2010. Sales within the area continue to be fuelled by Uzbekistan’s growing population and the trend towards self-medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Berlin-Chemie and Nycomed Pharma led cough, cold and allergy (hay fever) remedies sales in 2010, each recording a retail value share of 29%. Berlin-Chemie offers its Bromhexin and Falimint brands whilst Nycomed Pharma is mainly represented by Nazivin drops and sprays. The success of both companies can be attributed to their well-developed promotional strategies, long historical presence, and affordable prices.

PROSPECTS

  • Current trends within cough, cold and allergy (hay fever) remedies will continue over the coming years, with the availability of domestic brands expected to increase. Most importantly, the trend towards self-medication will continue to boost sales over the forecast period.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Oily, high calorie, and non-dietary cuisine has traditionally been a cause of digestive ailments in Uzbekistan. For example, plov is a traditional dish in Uzbekistan that is prepared from lamb or mutton that is browned in lamb fat or vegetable oil and then stewed for several hours with fried onions and carrots. In addition, plov is often served as early as 5am.

SWITCHES

COMPETITIVE LANDSCAPE

  • Berlin-Chemie strengthened its leadership in 2010, recording a retail value share of 39%. Meanwhile, Sanofi-Aventis’ sales share fell slightly to 34%. Radiks NPP, Galenika and SSP increased their sales shares to 11%, 3% and 2% respectively in 2010.

PROSPECTS

  • National dietary customs are not expected to change in Uzbekistan in the long term. As a result, demand for digestive remedies will remain high over the coming years.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Ear ailments have traditionally been considered as not being serious by consumers in Uzbekistan, with many consumers ignoring such problems. However, this situation is different in the case of children. As a result, most families have ear care products in their homes.

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis led ear care sales in 2010, recording a retail value share of 48% due to the popularity of its Sofradex brand. In addition, the generic product Bornaya Kislota from domestic producer Uzkhimpharm is also popular due to its comparatively cheap price and recorded a retail value share of 13% in 2010. Other brands with major sales are Aurisan Kapli from Ukrmedprom DAK and Otinum Kapli of ICN Pharmaceutical, which recorded respective retail value shares of 6% and 4%.

PROSPECTS

  • Current trends within eye care are expected to continue over the forecast period, with demand in the area expected to be fuelled by population growth. In addition, competition in the area will intensify, as minor companies, which account for almost one-third of total value sales in the area, will start to gain sales share as a result of successful cooperation agreements with medical centres. Ear care has a projected forecast period constant retail value CAGR of 1%.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Demand for eye care products continues to rise in Uzbekistan due to increasing computer usage and higher investment in advertising campaigns. In addition, recommendations from doctors that specialise in eye ailments is also helping to boost demand. As a result of such factors, eye care recorded current retail value growth of 12% in 2010, with sales reaching UZS2.3 billion.

COMPETITIVE LANDSCAPE

  • Demand for eye care products depends on price and perceived effectiveness. The fact that a number of cheap imported brands are available within the area means that there is little scope for domestic brands to compete. As a result, imports account for over 90% of sales within the area.

PROSPECTS

  • Eye care is expected to perform well over the forecast period for several reasons. Firstly, the number of people suffering from eye ailments is expected to increase due to rising computer and air conditioner usage.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares 2006-2010
  • Table 51 Eye Care Brand Shares 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Herbal and traditional products continue to increase in popularity thanks to the promotional efforts of manufacturers. Claims such as ‘contains natural and herbal ingredients’ are widely used to compete with other non-herbal products and have been very successful in attracting consumers and helped the area to record current retail value growth of 13% in 2010.

COMPETITIVE LANDSCAPE

  • Novo-Passit from Ivax Corp led sales in 2010, accounting for 24% of retail value sales. The brand’s success can be attributed to the domination of herbal and traditional calming and sleeping which accounted for 58% of total herbal and traditional retail value sales in 2010. Bronchicum from Sanofi-Aventis ranked second in 2010, recording a retail value share of 21%.

PROSPECTS

  • Herbal and traditional products is expected to continue to perform well and has a projected forecast period constant retail value CAGR of 3%, with demand in the area being fuelled by rising consumer interest in healthy ingredients.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care continues to develop, with rising consumer image awareness helping to boost demand for acne treatment, antifungals and medical shampoos. Sales of nappy (diaper) rash treatments are directly linked to improving consumer living standards and rising disposable incomes.

COMPETITIVE LANDSCAPE

  • Johnson & Johnson led sales in 2010, recording a retail value share of 16%. However, Radiks by Radiks NPP was the best-selling brand within the area, accounting for 15% of retail value sales. The success of this brand can be attributed to well organised distribution and competitive prices.

PROSPECTS

  • Medicated skin care has a projected forecast period constant retail value CAGR of 3%. Sales within the area will be boosted by continuous advertising activity and the expansion of chemists and pharmacies into rural areas.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares 2007-2010
  • Table 64 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Sports Nutrition in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition is extremely underdeveloped in Uzbekistan, with demand mainly being limited to serious sportsmen, athletes, swimmers and boxers.

COMPETITIVE LANDSCAPE

  • Company retail value share did not change at all in 2010, with all brands and companies recording similar growth.

PROSPECTS

  • Practicing sport is popular in Uzbekistan and physical exercise is strongly encouraged by the government. With government support, the number of gyms and sport centres has significantly increased throughout the country, including in rural areas. However, only individual sports centres in Tashkent city encourage consumption of sports nutrition products. Considering limited investment in promotional activities, there is unlikely to be significant increase in the availability of sports nutrition products over the coming years.

CATEGORY DATA

  • Table 66 Sales of Sports Nutrition: Value 2005-2010
  • Table 67 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 68 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 69 Sports Nutrition Company Shares 2006-2010
  • Table 70 Sports Nutrition Brand Shares 2007-2010
  • Table 71 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 72 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Table 73 Sports Nutrition, category rankings 2010

Vitamins and Dietary Supplements in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements continue to increase in popularity due to population growth, manufacturer promotional campaigns, and rising living standards.

Vitamins

Dietary Supplements

COMPETITIVE LANDSCAPE

  • Companies that offer vitamins lead sales due to the fact that the vitamins area is more developed. Krka continued to lead sales in 2010, recording a retail value share of 19%, and was followed by Unipharm (16%), and Galenika (Oligovit - 7%).

PROSPECTS

  • Vitamins and dietary supplements sales will continue to be fuelled by improving consumer living standards over the coming years. In addition, marketing campaigns and doctor recommendations will also help to boost sales over the coming years. As a result, vitamins and dietary supplements has a healthy projected forecast period constant retail value CAGR of 3%.

CATEGORY DATA

  • Table 74 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 75 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 76 Dietary Supplements by Positioning 2006-2010
  • Table 77 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 78 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 79 Vitamins Brand Shares 2007-2010
  • Table 80 Dietary Supplements Brand Shares 2007-2010
  • Table 81 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 82 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 6 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Weight management remains under developed in Uzbekistan, mainly due to the limited availability of such products. In addition, consumer interest in such products remains limited. In general, consumers in Uzbekistan do not suffer from obesity. Furthermore, both male and female consumers find it natural to gain weight as they age.

COMPETITIVE LANDSCAPE

  • Despite limited demand, there are at least four major weight management companies in Uzbekistan. Abott Laboratories led sales in 2010 thanks to the popularity of its Meridia brand. Babochka from Shenzhen Taitai Pharmaceutical ranked second, recording a retail value share of 20%, whilst Pokhudin from Leovit-Nutrio and Yabloko Pokhudeniya of Bional International ranked third and fourth, each with a retail value share of 12%.

PROSPECTS

  • Weight management has only limited growth potential for a number of reasons. Firstly, the fact that consumer eating habits are unlikely to change means that there will be no significant rise in obesity levels over the coming years. In addition, consumer attitudes towards weight gain are also unlikely to change. Furthermore, those consumers who are concerned with weight gain are more likely to turn towards exercise and healthier eating to slim down.

CATEGORY DATA

  • Table 83 Sales of Weight Management by Category: Value 2005-2010
  • Table 84 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 85 Weight Management Company Shares 2006-2010
  • Table 86 Weight Management Brand Shares 2007-2010
  • Table 87 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 88 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Uzbekistan - Category Analysis

HEADLINES

TRENDS

  • Wound Care continued to record steady growth during 2010 due to the fact that such products are increasingly perceived as being essential by consumers and are included within the majority of household medical boxes. In addition, the increase in the number of private medical centres in the country is also helping to boost growth within the area.

COMPETITIVE LANDSCAPE

  • Sarbontex JV continued to lead wound care value sales in 2010, accounting for 33% of retail value sales. This good performance can be attributed to the fact that Sarbontex JV is a local company and can consequently offer products at a lower price than international rivals. In addition, the fact the company is able to offer high quality products helps it to keep consumers satisfied. Furthermore, the company’s success can also be attributed to its strong distribution network.

PROSPECTS

  • Wound care has a projected forecast period constant retail value CAGR of 1%, with current demand trends expected to continue over the coming years.

CATEGORY DATA

  • Table 89 Sales of Wound Care by Category: Value 2005-2010
  • Table 90 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 91 Wound Care Company Shares 2006-2010
  • Table 92 Wound Care Brand Shares 2007-2010
  • Table 93 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 94 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking incidence

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

      RELATED

      Country Report

      Future Demographic